Ajanta Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2866.45

-9.25 (-0.32%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2866.45

-9.25 (-0.32%)
16:02 Dec 20

Quality

84/100
High Financial Strength

Valuation

27/100
Expensive Valuation

Technical

57/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	2889.69	3340.99	3742.64	4208.71	4490.79
Operating Expenses +	1891.13	2411.69	2959.39	3036.77	3256.88
Raw Material	795.95	915.44	1024.64	1105.78	1114.38
Increase Decrease in Cost	-150.9	-83.17	25.76	-39.21	-26.3
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	548.25	645.78	785.14	900.34	1009.6
Miscellaneous Expenses	876.91	1205.84	1416.41	1402.56	1159.2
Operating Profit	998.56	929.3	783.25	1171.94	1233.91
Other Income	25.98	115.68	98.64	84.6	95.04
Depreciation	116.09	125.3	130.8	135.4	136.87
Interest	8.27	10.2	5.84	7.21	10.77
Profit before tax and exceptio..	900.18	909.48	745.25	1113.93	1181.31
Exceptional Items	0	0	0	0	0
PBT	900.18	909.48	745.25	1113.93	1181.31
Provision for Taxation	246.31	196.8	157.27	297.76	306.31
Net Profit	653.87	712.68	587.98	816.17	875
NET Profit after MI	653.87	712.68	587.98	816.17	875
EPS	75.09	82.45	45.89	64.82	69.59
Operating Profit Margin (%)	34.56	27.82	20.93	27.85	27.48
Net Profit Margin (%)	22.63	21.33	15.71	19.39	19.48

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	66.30	66.30	66.20	66.20	66.20
FII	9.10	8.40	8.50	9.10	10.00
MF	14.90	14.80	14.80	13.90	12.80
Public	7.50	7.90	7.80	8.00	8.20
Others	0.00	0.00	0.00	0.00	0.00
Others	2.20	2.60	2.70	2.80	2.80